Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

Background: Hypoglycemia rates usually increase when insulin treatment is intensified to improve glycemic control. We evaluated (post hoc) hypoglycemic rates in adult patients with type 1 diabetes (T1D) on sotagliflozin (a dual sodium-glucose cotransporter [SGLT] 1 and 2 inhibitor) in two phase 3, 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Danne, Thomas, Pettus, Jeremy, Giaccari, Andrea, Cariou, Bertrand, Rodbard, Helena, Weinzimer, Stuart A., Bonnemaire, Mireille, Sawhney, Sangeeta, Stewart, John, Wang, Stella, Castro, Rita de Cassia, Garg, Satish K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708262/
https://www.ncbi.nlm.nih.gov/pubmed/31335194
http://dx.doi.org/10.1089/dia.2019.0157

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6708262/
https://www.ncbi.nlm.nih.gov/pubmed/31335194
http://dx.doi.org/10.1089/dia.2019.0157

Ejemplares similares